NEW YORK, Feb. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Generic and innovative drug market in CE countries 2011 is a unique new report that provides a detailed illustration of the current market conditions in Central Europe, both as one cohesive region and in the individual marketplaces of:
Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria.
In addition to the latest analysis of key effects of recent economic difficulties in these markets, this timely document provides comparative analysis, news on reimbursement policies and the development forecasts for 2011-2013 needed for success in this quickly changing industry.
The expert analysts at PMR Publications have closely examined the issues that affect market conditions and require skillful navigation within today's CE generic and innovative drug market:
insurers, exclusivity of data regulations
formula patent time periods
They have carefully compiled their research, analysis and projections to create a single concise and cost-effective document that saves readers time and money by offering the widest scope of necessary coverage without sacrificing any of the required detail.
The report presents a sharply-focused view of the future by predicting changes in market size and share for the coming two years, as well as in-depth treatment of current and future reimbursement lists and processes and their impact on the market. It examines VAT rates, and outlines expected changes in data exclusivity periods allotted to innovative medicine companies.
Readers will gain an insightful understanding of the behaviour and reasoning of market participants through detailed description of:
the preferences of the consumer, medical patient and prescribing physician concerning generics and innovative drugs
company profiles that spotlight the activities and achievements of the largest developers, manufacturers and distributors of the many products that are classified in this specific portion of the region's pharmaceutical market.
Copyright©2010 PR Newswire.
All rights reserved